(Q36836080)

English

Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies

scientific article published on 3 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Debra M Sarasohn

object named as

Debra Sarasohn

6

0 references

object named as

Paul Hamlin

3

0 references

Andrew D Zelenetz

object named as

Andrew D Zelenetz

17

0 references

Owen A O'Connor

1

object named as

Owen A O'Connor

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Steven M Horwitz

2

object named as

Steven Horwitz

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Carol Portlock

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Craig H Moskowitz

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Ellen Neylon

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jill Mastrella

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Rachel Hamelers

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Barbara Macgregor-Cortelli

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Molly Patterson

11

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Venkatraman E Seshan

12

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Frank Sirotnak

13

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Martin Fleisher

14

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Diane R Mould

15

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Mike Saunders

16

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

3 August 2009

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

27

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

26

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

4357-4364

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

29 September 2017

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

29 September 2017

Carrier-mediated membrane transport of folates in mammalian cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

29 September 2017

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

29 September 2017

High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

29 September 2017

New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

27 June 2018

Methotrexate and citrovorum factor rescue in the management of childhood lymphosarcoma and reticulum cell sarcoma (non-Hodgkin's lymphomas): parolonged unmaintained remissions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

27 June 2018

A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

5 September 2018

The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

5 September 2018

Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

5 September 2018

10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651599

5 September 2018

Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19652067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New folate analogs of the 10-deaza-aminopterin series. Basis for structural design and biochemical and pharmacologic properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/19652067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New folate analogs of the 10-deaza-aminopterin series. Further evidence for markedly increased antitumor efficacy compared with methotrexate in ascitic and solid murine tumor models

1 reference

https://pubmed.ncbi.nlm.nih.gov/19652067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

10-Ethyl-10-deaza-aminopterin: structural design and biochemical, pharmacologic, and antitumor properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/19652067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RFC-1 gene expression regulates folate absorption in mouse small intestine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19652067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19652067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2008.20.8470

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36836080&oldid=1721042090"